Thanomsak Anekthananon
Biographic Data
| ID | 7731530 |
|---|---|
| NAME | Thanomsak Anekthananon |
| GIVEN NAMES | Thanomsak |
| FAMILY NAME | Anekthananon |
| SIGNATURE | ANEKTHANANON T |
| AFFILIATIONS | Siriraj Hospital |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2019 |
| LATEST PUBLICATION YEAR | 2019 |
| H-INDEX | 0 |
Slow Acceptance of Universal Antiretroviral Therapy (ART) Among Mothers Enrolled in Impaact PROMISE Studies Across the Globe
The PROMISE trial enrolled asymptomatic HIV-infected pregnant and postpartum women not eligible for antiretroviral treatment (ART) per local guidelines and randomly assigned proven antiretroviral strategies to assess relative efficacy for perinatal prevention plus maternal/infant safety and maternal health. The START study subsequently demonstrated clear benefit in initiating ART regardless of CD4 count. Active PROMISE participants were informed …
No prominent works on this page.
Slow Acceptance of Universal Antiretroviral Therapy (ART) Among Mothers Enrolled in Impaact PROMISE Studies Across the Globe
The PROMISE trial enrolled asymptomatic HIV-infected pregnant and postpartum women not eligible for antiretroviral treatment (ART) per local guidelines and randomly assigned proven antiretroviral strategies to assess relative efficacy for perinatal prevention plus maternal/infant safety and maternal health. The START study subsequently demonstrated clear benefit in initiating ART regardless of CD4 count. Active PROMISE participants were informed …
Adolescent Sexual and Reproductive Health (1 works) · Alternative medicine (1 works) · Antiretroviral therapy (1 works) · Asymptomatic (1 works) · Environmental health (1 works) · Family medicine (1 works) · Health psychology (1 works) · HIV, Drug Use, Sexual Risk (1 works) · HIV/AIDS Research and Interventions (1 works) · Human immunodeficiency virus (HIV (1 works)